These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17671110)

  • 1. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
    Cohen EE
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
    Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new marker determining clonal outgrowth.
    Mao L
    Clin Cancer Res; 2002 Jul; 8(7):2021-3. PubMed ID: 12114399
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
    Ha PK; Tong BC; Westra WH; Sanchez-Cespedes M; Parrella P; Zahurak M; Sidransky D; Califano JA
    Clin Cancer Res; 2002 Jul; 8(7):2260-5. PubMed ID: 12114429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.
    Kim MM; Clinger JD; Masayesva BG; Ha PK; Zahurak ML; Westra WH; Califano JA
    Clin Cancer Res; 2004 Dec; 10(24):8512-5. PubMed ID: 15623632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can molecular assessment improve classification of head and neck premalignancy?
    Mao L
    Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
    [No Abstract]   [Full Text] [Related]  

  • 7. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants.
    Wenig BM
    Mod Pathol; 2002 Mar; 15(3):229-54. PubMed ID: 11904340
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
    Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
    Partridge M
    Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.
    Lièvre A; Blons H; Houllier AM; Laccourreye O; Brasnu D; Beaune P; Laurent-Puig P
    Br J Cancer; 2006 Mar; 94(5):692-7. PubMed ID: 16495928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.
    Sanchez-Cespedes M; Parrella P; Nomoto S; Cohen D; Xiao Y; Esteller M; Jeronimo C; Jordan RC; Nicol T; Koch WM; Schoenberg M; Mazzarelli P; Fazio VM; Sidransky D
    Cancer Res; 2001 Oct; 61(19):7015-9. PubMed ID: 11585726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic factors associated with head and neck cancer.
    Br Dent J; 2007 Jan; 202(2):58. PubMed ID: 17255975
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aurora sheds light on head and neck squamous cell carcinoma.
    Han H; Von Hoff DD
    Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical Composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells.
    Sertel S; Eichhorn T; Plinkert PK; Efferth T
    Anticancer Res; 2011 Jan; 31(1):185-91. PubMed ID: 21273597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of biomarkers in head and neck cancer.
    Chang SS; Califano J
    J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry. Tumour DNA content and prognosis in squamous cell carcinoma of the head and neck region: a review.
    Richards A
    Penn Dent J (Phila); 1988; 89(1):3-5. PubMed ID: 15487847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.